The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis
NCT01248598 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2010-11-25
Summary
The purpose of this study is to study the prevalence of EBV, HCMV, HHV-6 in saliva and on the toothbrush patient with periodontitis.
Conditions
- Cytomegalovirus
- Epstein-Barr Virus Infections
- Herpesvirus Infection
Sponsors & Collaborators
-
Rambam Health Care Campus
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
Countries
- Israel
Study Locations
More Related Trials
-
Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy
NCT02351102 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants
NCT06145178 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
NCT00002377 ·Status: COMPLETED ·Phase: PHASE3
-
PTH - Preemptive Treatment for Herpesviridae
NCT02152358 ·Status: COMPLETED ·Phase: PHASE4
-
Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
NCT00002024 ·Status: COMPLETED ·Phase: NA
-
Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19
NCT04444596 ·Status: UNKNOWN ·Phase: NA
-
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS
NCT00002273 ·Status: COMPLETED ·Phase: NA
-
AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients
NCT04690933 ·Status: COMPLETED
-
Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV
NCT02798692 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults
NCT02826798 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis
NCT00002134 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus
NCT02439957 ·Status: TERMINATED ·Phase: PHASE3
-
The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV
NCT00001034 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002299 ·Status: COMPLETED ·Phase: NA
-
Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV
NCT00006145 ·Status: COMPLETED ·Phase: PHASE3
-
A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis
NCT00000698 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS
NCT00000989 ·Status: COMPLETED ·Phase: NA
-
Maribavir for Prevention of CMV After Stem Cell Transplants
NCT00223925 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment
NCT06870539 ·Status: COMPLETED
-
Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes
NCT03586284 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults
NCT03382405 ·Status: COMPLETED ·Phase: PHASE1
-
Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS
NCT00000693 ·Status: COMPLETED ·Phase: NA
-
A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS
NCT00002257 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease
NCT02439970 ·Status: TERMINATED ·Phase: PHASE3
-
A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS
NCT00000688 ·Status: COMPLETED ·Phase: PHASE3